Navigation Links
Aspirin May Increase Risk of Crohn's Disease
Date:5/3/2010

But experts add that painkiller's other health benefits may outweigh possible link

MONDAY, May 3 (HealthDay News) -- A new British study finds that people who take aspirin every day have a higher risk of developing Crohn's disease, a potentially devastating digestive illness.

But it's still not very likely that aspirin users will develop the condition, and the study's lead author said patients should keep in mind that aspirin lowers the risk of heart disease.

"If the link with aspirin is a true one, then only a small proportion of those who take aspirin -- approximately one in 2,000 -- may be at risk," said study author Dr. Andrew Hart, a senior lecturer in gastroenterology at University of East Anglia School of Medicine. "If aspirin has been prescribed to people with Crohn's disease or with a family history by their physician, then they should continue to take it. Aspirin has many beneficial effects and should be continued."

An estimated 500,000 people in the United States have Crohn's disease, which causes digestive problems and can boost the risk of bowel cancer. In some cases, patients must undergo surgery; many have to take medications for the rest of their lives.

While aspirin is known for its ability to reduce the risk of heart disease, it can cause stomach ulcers, and research in animals has suggested it can be hard on the intestines, too. The study authors decided to see if it had the same effect in humans, Hart said.

In the new study, researchers tracked 200,000 volunteers, aged 30 to 74, from several European countries.

The researchers found that aspirin use for a year or more boosted the risk of Crohn's disease by five times.

However, the study only suggests there's a link between aspirin use and the disease; it doesn't prove that aspirin actually increased the risk. And the researchers didn't know how much aspirin each person took.

Why might aspirin boo
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. In Women, Aspirin Might Ward Off Eye Trouble
2. Aspirin During Pregnancy May Help Preemies
3. Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages
4. Aspirin May Boost Breast Cancer Survival
5. Cardiologists Comment on Aspirin Versus Resveratrol
6. Aspirin Alone Works Best to Prevent Clots a Year After Stenting
7. Connecture, Inc. Launches New Technology Package to Increase Health Insurance Carriers' Success in the Online Individual Market
8. Cocaine or ecstasy consumption during adolescence increases risk of addiction
9. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
10. Genes of pregnant women and their fetuses can increase the risk of preterm labor
11. NIH scientists identify maternal and fetal genes that increase preterm birth risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... Adolescents, especially young males, who experiment ... “K2” are landing in emergency rooms across America. ... epidemic with a new treatment program for those ... research from the National Institute on Drug Abuse, synthetic ... American teenagers. In 2012, 11 percent of high school ...
(Date:5/18/2013)... DF (PRWEB) May 18, 2013 The ... leading ayurvedic education institution in the West. Program is ... education. , Ayurveda is a healing modality practiced for ... ), it is considered that health begins when an ... profound understanding of their individual needs. Ayurveda aims to ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 Rio ... has recently completed a stylish renovation that features tranquil, ... specialties. , From the ground up, this Morro ... with fresh flooring, soothing colors and comfortable spa beds. ... installed, including an Apilus epilator machine. The shampoo ...
(Date:5/18/2013)... 2013 Losing weight remains to be the ... horde of new weight loss products available in the market ... studies about this newest weight loss supplement prove that dieting ... , Garcinia Cambogia is a sub-tropical fruit that is shaped ... fruit can suppress a person’s appetite, while it effectively burns ...
(Date:5/18/2013)... 2013 Spectrum Surgical Instruments will ... 17-22 in Austin, TX where thousands of GI ... networking opportunities. , Spectrum Surgical/STERIS will feature ... repair capabilities and certified pre-owned equipment. Attendees ... on proper instrument care of flexible endoscopes. ...
Breaking Medicine News(10 mins):Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2
... Feb. 11 Abbott ( NYSE: ABT ),today ... Food and Drug,Administration (FDA) for its new, compact ... expand the company,s hematology,platform by offering a high ... laboratories. , As small ...
... Inc., a privately held company located in the Midwest, ... eliminates all of the most common problems associated with ... therapy hasn,t always been therapeutic for many people. The ... never continue therapy beyond the first night ... because ...
... Tibotec Therapeutics, a division of Centocor Ortho ... a lower-dose (75 mg) formulation of PREZISTA (darunavir) ... the FDA approval of PREZISTA, co-administered with ritonavir ... treatment of HIV infection in pediatric patients six ...
... Men, Women Differ in Oral Health Care Habits , CHICAGO, ... what do people find most attractive in others? The smile. ... Crest(R) and Oral B(R) finds that the smile outranked eyes, ... men and women differ when it comes to taking care ...
... Ongoing Study Shows Seven of 14 Evaluable Patients ... Two Treatment Cycles----Bavituximab Has Now Produced Positive Early ... Therapy Cancer Trials--TUSTIN, Calif., Feb. 11 Peregrine ... reported that its lead product candidate bavituximab achieved ...
... Sanofi-aventis announced today that Jean-Pierre ... Chief Medical Officer (CMO). He was previously Senior ... Marc Cluzel, Senior Vice President, Research & Development, who ... Officer is a further demonstration internally and externally of ...
Cached Medicine News:Health News:Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument 2Health News:Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument 3Health News:Husband From Small Town May Have Found Solution to Sleep Industry's 20-Year Compliance Problem 2Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 2Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 3Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 4Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 5Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 6Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 7Health News:Survey Finds Smile is 'Most Attractive' Physical Feature 2Health News:Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study 2Health News:Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study 3Health News:Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study 4Health News:Jean-Pierre Lehner Appointed Chief Medical Officer 2
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- United Medical Education, ... Life Support (ACLS), Pediatric Advanced Life Support (PALS) and ... BLS and ACLS online course manuals. In ... simply need to build an account with the company. ... these programs, United Medical Education is setting a precedent ...
(Date:5/17/2013)... BOSTON , May 17, 2013  TechAtlas ... update for their competitive landscape map for the ... highlights over 90 international companies with drugs and ... addressing CKD and its sequelae. ... include: , hypertension - renal denervation ...
(Date:5/17/2013)... Conn. , May 17, 2013 /PRNewswire-iReach/ -- ... and recombinant proteins, is placing renewed emphasis on ... the rise as a number of factors are ... for pharmaceutical makers and their delivery device partners ... previously refractory conditions, the growing trend toward self-administration ...
Breaking Medicine Technology:ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
... 11, 2011 Conatus Pharmaceuticals Inc. today announced the ... private placement financing.  This financing was led by new ... participation by existing investors; Aberdare Ventures, Advent Venture Partners, ... Fund.  Conatus will use the proceeds to advance the ...
... 2011 Stryker Corporation,s (NYSE: SYK ) ... 510(k) clearance for its MDM X3 Modular Dual Mobility ... to the company,s portfolio of next-generation technologies designed to ... and address a broader patient population, including both primary ...
Cached Medicine Technology:Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing 2Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System 2Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System 3
...
Solid blade speculum designed for both temporal and superior approach ocular surgery. Adjustable with thumb screw. Manufactured in titanium....
Adjustable lid speculum angled 45 degrees with 17 mm curved solid blades and aspiration ports to remove excess fluid from around the eye during ocular procedures....
Adjustable lid speculum with mm blades. Miniature frame ideal for deep set eyes and small orbital structures....
Medicine Products: